This is the authors' abstract. We don't add key points for this paper.
Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older people.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rolland et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: